AeenaDx

AeenaDx is a pioneering company within the Biotechnology and Health Care sectors, focused on developing groundbreaking non-invasive disease diagnostic and screening platforms. Founded in 2011, this U.S.-based company is gaining attention for its innovative approach to health diagnostics via saliva self-collection, promising a transformative leap into the future of home-based health monitoring.

The company, currently in stealth mode, positions itself as a visionary force with its slogan, “The future...at home saliva self-collection for the detection of cancers and disease.” This innovative direction underscores its commitment to providing accessible and effective diagnostic solutions.

AeenaDx secured a Series A investment on 01 June 2022 from Portfolia, indicating healthy investor confidence and validating the potential of its technology. Investors might find the company's focus on non-invasive diagnostics appealing, given the growing demand for accessible health solutions. As the company continues to evolve, its developments could significantly impact the diagnostic landscape.